Initial Experience of an Automated Anastomotic Distal Device in Off-Pump CABG
Background: Recent progress in minimally invasive technology in the field of coronary artery bypass grafting (CABG) stimulates interest in anastomotic devices used to facilitate distal coronary anastomosis. We assessed the feasibility of the automated anastomotic distal device (AADD) on arterial grafts in patients who underwent off-pump CABG (OPCAB) and evaluated the early anastomotic patency and clinical results of the AADD based on an elliptical nitinol ring with attached 8 pins.
Methods: Fourteen patients scheduled for multivessel OPCAB using arterial grafts between August 2003 and February 2004 were studied. Among 19 patients enrolled, 5 patients were excluded: 2 patients because of failure of graft flaring onto the implant pins, 2 because of small and diseased target coronary artery (<1.5 mm in diameter), and 1 because of conversion to cardiopulmonary bypass. The distal anastomosis using the AADD was performed for the nondominant coronary artery.
Results: The total number of distal anastomoses was 48 (34 hand-sewn sutures and 14 AADD sutures), and the average number of distal anastomoses per patient was 3.4 ± 1.0. The grafts used for the AADD were right gastroepiploic artery (RGEA) in 10 patients, saphenous vein anastomosed to the end of the RGEA in 2 patients, and internal thoracic artery in 2 patients. The average time required for distal anastomosis using the AADD (from arteriotomy to anastomosis completion) was 2.9 ± 0.7 minutes (range, 1.5-4 minutes). The mean flow and pulsatility index of the AADD grafts measured intraoperatively by transit time flow measurement were 20.0 ± 10.3 mL/min and 2.4 ± 1.2, respectively. Early postoperative coronary angiographies demonstrated widely patent grafts in 32 of 34 hand-sewn anastomoses and 13 of 14 AADD sutures. There were no adverse events related to the use of the device.
Conclusions: Our initial experience demonstrated that distal anastomosis using the AADD was feasible in most of the patients who underwent OPCAB using arterial grafts. Distal anastomosis using the AADD had the advantage of shortening the actual suturing duration and might provide a method for standardizing the anastomotic procedure.
Chavanon O, Perrault LP. 1999. Favorable aspect of stapled anastomosis: an endothelial function study. Ann Thorac Surg 68:1443-4.nEckstein FS, Bonilla LF, Englberger L, et al. 2002. First clinical results with a new mechanical connector for distal coronary artery anastomoses in CABG. Circulation 106:I1- 4.nEmery RW, Eales F, Van Meter CH Jr, et al. 2001. Ventriculocoronary artery bypass results using a mesh-tipped device in a porcine model. Ann Thorac Surg 72:S1004-8.nFilsoufi F, Farivar RS, Aklog L, et al. 2004. Automated distal coronary bypass with a novel magnetic coupler (MVP system). J Thorac Cardiovasc Surg 127:185-92.nGundry SR, Black K, Izutani H. 2000. Sutureless coronary artery bypass with biologic glued anastomoses: preliminary in vivo and in vitro results. J Thorac Cardiovasc Surg 120:473-7.nKim K-B, Cho KR, Chang W-I, Lim C, Ham BM, Kim YL. 2002. Bilateral skeletonized internal thoracic artery graftings in off-pump coronary artery bypass: early result of Y versus in situ grafts. Ann Thorac Surg 74:S1371-7.nNataf P, Hinchliffe P, Manzo S, et al. 1998. Facilitated vascular anastomoses: the one-shot device. Ann Thorac Surg. 66:1041-4.nSchaff HV, Zehr KJ, Bonilla LF, et al. 2002. An experimental model of saphenous vein-to-coronary artery anastomosis with the St. Jude medical stainless steel connector. Ann Thorac Surg 73:830-6.nScheltes JS, Heikens M, Pistecky PV, et al. 2000. Assessment of patented coronary end-to-side anastomotic devices using micromechanical bonding. Ann Thorac Surg 70:218-22.nSolem JO, Boumzebra D, Al-Buraiki J, et al. 2000. Evaluation of a new device for quick sutureless coronary artery anastomosis in surviving sheep. Eur J Cardiothoracic Surg 17:1046-8.nZehr KJ, Hamner CE, Bonilla LF, et al. 2003. Evaluation of a novel 2mm internal diameter stainless steel saphenous vein to coronary artery connector: laboratory studies of on-pump and off-pump revascularization. Eur J Cardiothorac Surg 23:925-34.nBar-El Y, Tio FO, Shofti R. 2003. An automatic sutureless coronary anastomotic device: initial results of an animal study. Heart Surg Forum 6:369-74.nBass LS, Treat MR, Dzakonski C, et al. 1989. Sutureless microvascular anastomosis using the THC: YAG laser: a primarily report. Microsurgery 10:189-93.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).